• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Nippon Chemi-Con Corporation (6997) - Financial and Strategic SWOT Analysis Review

  • ID: 2011963
  • September 2014
  • 32 pages
  • GlobalData

Nippon Chemi-Con Corporation (6997) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

Note: Product cover images may vary from those shown

List of Tables
List of Figures
Section 1 - About the Company
Nippon Chemi-Con Corporation - Key Facts
Nippon Chemi-Con Corporation - Key Employees
Nippon Chemi-Con Corporation - Key Employee Biographies
Nippon Chemi-Con Corporation - Major Products and Services
Nippon Chemi-Con Corporation - History
Nippon Chemi-Con Corporation - Company Statement
Nippon Chemi-Con Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Nippon Chemi-Con Corporation - Business Description
Nippon Chemi-Con Corporation - SWOT Analysis
SWOT Analysis - Overview
Nippon Chemi-Con Corporation - Strengths
Strength - Global Presence
Strength - Strong Operational Performance
Strength - Focused R&D Activities
Strength - Strong liquidity
Nippon Chemi-Con Corporation - Weaknesses
Weakness - Large Outstanding Long Term Debt
Nippon Chemi-Con Corporation - Opportunities
Opportunity - Focus on Emerging Countries
Opportunity - Positive Outlook for EMS
Opportunity - New Product Development
Nippon Chemi-Con Corporation - Threats
Threat - Intense Competition
Threat - Earthquakes and Other Natural Disasters
Threat - Foreign Currency Fluctuations
Nippon Chemi-Con Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Appendix
Ratio Definitions
About Us
Contact Us

List of Tables
Nippon Chemi-Con Corporation, Key Facts
Nippon Chemi-Con Corporation, Key Employees
Nippon Chemi-Con Corporation, Key Employee Biographies
Nippon Chemi-Con Corporation, Major Products and Services
Nippon Chemi-Con Corporation, History
Nippon Chemi-Con Corporation, Other Locations
Nippon Chemi-Con Corporation, Key Competitors
Nippon Chemi-Con Corporation, Ratios based on current share price
Nippon Chemi-Con Corporation, Annual Ratios
Nippon Chemi-Con Corporation, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Nippon Chemi-Con Corporation, Performance Chart (2010 - 2014)
Nippon Chemi-Con Corporation, Ratio Charts

Note: Product cover images may vary from those shown

Japan Resistor Mfg. Co., Ltd.
Tokyo Cosmos Electric Co., Ltd.
Ralec Electronic Corporation
KOA Corporation
Sancon Jetwell ( Haimen ) Electronics Co. Ltd

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.